CellSource Co (TSE:4880) Accounts Payable & Accrued Expense : 円147 Mil (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CellSource Co Accounts Payable & Accrued Expense?

CellSource Co's quarterly accounts payable & accrued expense increased from Jul. 2023 (円203 Mil) to Oct. 2023 (円241 Mil) but then declined from Oct. 2023 (円241 Mil) to Jan. 2024 (円147 Mil).

CellSource Co's annual accounts payable & accrued expense increased from Oct. 2021 (円544 Mil) to Oct. 2022 (円726 Mil) but then declined from Oct. 2022 (円726 Mil) to Oct. 2023 (円241 Mil).

CellSource Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for CellSource Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co Accounts Payable & Accrued Expense Chart

CellSource Co Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

133.74

229.16

543.91

725.74

241.00

CellSource Co Quarterly Data
	Oct18	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															168.19	329.19	202.63	241.00	146.72

CellSource Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

CellSource Co (TSE:4880) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002

Website

https://www.cellsource.co.jp

CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines